Cardiovascular diseases remain a major global health challenge, driving ongoing scientific research into preventative strategies and dietary components [3]. Among these, omega-3 polyunsaturated fatty acids—specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA)—have been extensively studied for their potential roles in supporting heart health and managing metabolic conditions [3, 7]. While their benefits are widely recognized, researchers continue to investigate the precise mechanisms by which these fatty acids interact with the cardiovascular system.
Inflammatory Pathways and Systemic Effects
Chronic inflammation is closely linked to the progression of cardiovascular conditions [2]. Research involving patients with stable coronary artery disease on statin therapy looked at whether supplementation with EPA and DHA could alter inflammatory markers [2]. The analysis observed that participants receiving these fatty acids experienced lower levels of specific localized and systemic inflammatory indicators, such as reduced systemic neutrophil-to-lymphocyte ratios, compared to control groups [2]. Additionally, omega-3 fatty acids possess known anti-inflammatory properties that help modulate metabolic pathways involving lipid regulation [6, 7].
Cardiovascular Outcomes and Atrial Fibrillation
The impact of EPA and DHA supplementation on major adverse cardiovascular events and the risk of atrial fibrillation (AF) has been evaluated through various systematic reviews and meta-analyses [3]. Atrial fibrillation involves complex mechanistic pathways, and researchers frequently track specific serum biomarkers—such as high-sensitivity troponin T, NT-pro-BNP, and C-reactive protein—to understand cardiac stress and inflammation over time [1]. Large population and clinical studies, including investigations into older adults with metabolic syndrome, help clarify whether habitual dietary intake of marine-derived omega-3 fatty acids alters the longitudinal trajectories of these heart-related biomarkers [1].
Metabolic Interactions and Plaque Burden
Beyond systemic inflammation, researchers analyze how plasma fatty acid profiles relate to the structural burden of coronary artery disease [4]. Observational studies utilizing coronary computed tomographic angiography (CCTA) have evaluated parameters like coronary artery calcium scores and plaque characteristics in relation to circulating fatty acids [4]. Furthermore, experimental models indicate that high-dose EPA supplementation can influence cardiac lipidomic signatures, lower circulating triglycerides, and support cardiac function following acute events like myocardial infarction [8]. In broader population cohorts, lower circulating polyunsaturated fatty acid concentrations have occasionally been observed in individuals with specific cardiac remodeling patterns, though demographic and genetic risk factors also play substantial roles [5].
Considerations for Dietary Integration
While omega-3 fatty acids offer promising metabolic and anti-inflammatory benefits—such as triglyceride reduction and lipid metabolism modulation via specific receptor pathways—their clinical outcomes can vary depending on dosage, formulation, and patient subgroups [3, 7]. Understanding these nuances helps clinicians and researchers better interpret how nutritional science intersects with standard cardiovascular care. Patients interested in modifying their supplement routines or dietary intake should always consult qualified healthcare professionals to ensure safe and personalized management.
Sources
- [1] Effect of Omega-3 Fatty Acid Intake on Circulating Biomarkers of Atrial Fibrillation-Related Pathways in the PREDIMED-Plus Study. PubMed
- [2] Omega-3 fatty acids and oral and systemic inflammation: A secondary analysis of a randomized trial in patients with coronary artery disease. PubMed
- [3] Meta Analysis of DHA and EPA Supplementation on Cardiovascular Outcomes and Atrial Fibrillation Risk. PubMed
- [4] Plasma fatty acid profiles and coronary artery disease burden assessed by coronary CT angiography: an observational study. PubMed
- [5] The Role of Circulating Polyunsaturated Fatty Acids in Atrial Fibrillation and Atrial Cardiomyopathy: A Machine Learning-Informed Structural Modelling Approach. PubMed
- [6] Serum Omega-3 Fatty Acids and Obesity-Comorbid Depression in US Adults: An Integrated Epidemiology and Network Pharmacology Study. PubMed
- [7] Omega-3 Fatty Acids and Exercise in Obesity Management: Independent and Synergistic Benefits in Metabolism and Knowledge Gaps. PubMed
- [8] Eicosapentaenoic acid ethyl ester, cardiac metabolomic and lipidomic signatures, and cardioprotection in myocardial infarction. PubMed